OncTimes Talk

OncTimes Talk

Por: Oncology Times
OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.
100 episodios disponibles

Latest episodes of the podcast OncTimes Talk

Mostrando página 2 de 5

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified 13/01/2025
Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified 10/01/2025
Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development 10/01/2025
Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma 10/01/2025
Clear Benefit From Early Checkpoint Inhibition in Locally Advanced, High-Risk Cervical Cancer 10/01/2025
The New Standard: Testing for All Therapy-Matched DNA and RNA Biomarkers Up Front 31/12/2024
Digital Twin Brings AI Power to Individualize Cancer Management 25/12/2024
Wnt Signaling Pathway Inhibitor Suggests Toxicity-Free Cure Potential for Hepatoblastoma 25/12/2024
Anti-HER2 Combination Found Effective in HER2-Altered Bile Duct Cancers 12/12/2024
FGFR-3 Inhibitor Has Early Clinical Activity in Advanced Urothelial Cancer 19/11/2024
Radiation Delivery by Mini Protein Brings Promise for Metastatic Urothelial & Other Solid Tumors 15/11/2024
Antibody-Drug Conjugate "Promising Efficacy" in HER2-Positive and HER2-Low Breast Cancer 15/11/2024
Advanced Melanoma: CheckMate 067 10-Year Data Show Prognoses Transformed By Checkpoint Inhibitors 30/10/2024
Preoperative Chemoradiation Ruled Out for Gastric or GE Junction Resectable Adenocarcinoma 30/10/2024
Perioperative Checkpoint Inhibition Better for Muscle-Invasive Bladder Cancer 30/10/2024
Recurrent Glioma: Encouraging Responses to Autologous Myeloid Dendritic Cell Therapy 30/10/2024
Therapeutic mRNA Vaccine Brings New Hope in Glioblastoma 23/10/2024
Resectable Stage III Melanoma: Unprecedented Survival Benefit With Pure Checkpoint Inhibitor Neoadjuvant Therapy 23/10/2024
Circulating Tumor DNA Directs Precision Management for Ovarian Cancer 15/10/2024
ESMO Reports Neoadjuvant Therapy for TNBC, Combination Checkpoint Inhibition, Artificial Intelligence & More 14/10/2024
« Primera ‹ Anterior 1 2 3 4 5 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA